The AtheNA Multi-Lyte® Test System* is a multiplexed,
fluorescent, bead-based system designed to simultaneously perform
multiple assays from a single sample all in one well. It offers a
simple and streamlined alternative to IFA and ELISA testing,
providing improved clinical sensitivity and comparable clinical
specificity in a labor-saving, automation-friendly format. The
AtheNA assay protocol features only two 30-minute incubations with
windows of +/- 10 minutes. Customized
software has been designed for easy data reduction, concise
specimen reports and user-friendly data management
applications.
AtheNA autoimmune disease systems available today include the
AtheNA Multi-Lyte® ANA Test
System, which simultaneously performs ANA screening and reflex
testing for 9 specific auto-antibodies (SSA, SSB, Sm, RNP, Scl-70,
Jo-1, dsDNA, Centromere B and Histone) in a single well, the
AtheNA Multi-Lyte® ANCA Test
System, the AtheNA Multi-Lyte®
Rheumatoid Factor Test System, and the AtheNA Multi-Lyte® TPO/Tg Test
System.
AtheNA technology is not limited to autoimmune testing. Its
multiplexing capability promises to revolutionize other areas of diagnostic testing as well.
Virtually any assay that can be performed in an ELISA microtiter
format can be adapted to the AtheNA platform. For instance, in the
area of infectious disease testing, Inverness Medical Professional
Diagnostics offers the AthenNA Multi-Lyte®
EBV IgG Test System and the AtheNA
Multi-Lyte® EBV VCA IgM Test System. Several additional
infectious disease applications including ToRCH, HSV 1 & 2 and
MMRV are currently under development.
*All AtheNA Multi-Lyte® serological
assays have been developed and are manufactured by Zeus Scientific,
Inc., and are marketed exclusively by Inverness Medical
Professional Diagnostics, a member of the Inverness Medical family.
Each is composed of a bench-top flow analyzer and differentially
dyed and distinguishable microspheres developed by the Luminex
Corporation.